ITPA

ITPA
Identifiers
AliasesITPA, C20orf37, HLC14-06-P, dJ794I6.3, My049, ITPase, NTPase, inosine triphosphatase, DEE35
External IDsOMIM: 147520; MGI: 96622; GeneCards: ITPA
Available structures
PDBOrtholog search: PDBe RCSB
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
3.6.1.66
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_025922
NM_001362648

RefSeq (protein)

NP_080198
NP_001349577

Location (UCSC)Chr 20: 3.21 – 3.22 MbChr 2: 130.51 – 130.52 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Inosine triphosphate pyrophosphatase is an enzyme that in humans is encoded by the ITPA gene,[5][6] by the rdgB gene in bacteria E.coli[7] and the HAM1 gene in yeast S. cerevisiae;[8] the protein is also encoded by some RNA viruses of the Potyviridae family.[9] Two transcript variants encoding two different isoforms have been found for this gene. Also, at least two other transcript variants have been identified which are probably regulatory rather than protein-coding.[citation needed]

Function

The protein encoded by this gene hydrolyzes inosine triphosphate and deoxyinosine triphosphate to the monophosphate nucleotide and diphosphate.[6] The enzyme possesses specificity to multiple substrates, and acts on other nucleotides including xanthosine triphosphate and deoxyxanthosine triphosphate.[8] The encoded protein, which is a member of the HAM1 NTPase protein family, is found in the cytoplasm and acts as a homodimer.

Clinical significance

Defects in the encoded protein can result in inosine triphosphate pyrophosphorylase deficiency.[6] The enzyme ITPase dephosphorylates ribavirin triphosphate in vitro to ribavirin monophosphate, and reduced ITPase activity in 30% of humans potentiates mutagenesis in hepatitis C virus.[10] Gene variants predicting reduced predicted ITPase activity have been associated with decreased risk of ribavirin-induced anemia, increased risk of thrombocytopenia, lower ribavirin concentrations, as well as a ribavirin-like reduced relapse risk following interferon-based therapy for hepatitis C virus (HCV) genotype 2 or 3 infection.[11]

Further reading

  • Holmes SL, Turner BM, Hirschhorn K (1979). "Human inosine triphosphatase: catalytic properties and population studies". Clinica Chimica Acta; International Journal of Clinical Chemistry. 97 (2–3): 143–153. doi:10.1016/0009-8981(79)90410-8. PMID 487601.
  • Fraser JH, Meyers H, Henderson JF, Brox LW, McCoy EE (December 1975). "Individual variation in inosine triphosphate accumulation in human erythrocytes". Clinical Biochemistry. 8 (6): 353–364. doi:10.1016/S0009-9120(75)93685-1. PMID 1204209.
  • Clawson GA, Song YL, Schwartz AM, Shukla RR, Patel SG, Connor L, et al. (November 1991). "Interaction of human immunodeficiency virus type I Rev protein with nuclear scaffold nucleoside triphosphatase activity". Cell Growth & Differentiation. 2 (11): 575–582. PMID 1667585.
  • Sumi S, Marinaki AM, Arenas M, Fairbanks L, Shobowale-Bakre M, Rees DC, et al. (October 2002). "Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency". Human Genetics. 111 (4–5): 360–367. doi:10.1007/s00439-002-0798-z. PMID 12384777. S2CID 24240940.
  • Cao H, Hegele RA (2003). "DNA polymorphisms in ITPA including basis of inosine triphosphatase deficiency". Journal of Human Genetics. 47 (11): 620–622. doi:10.1007/s100380200095. PMID 12436200.
  • Marinaki AM, Duley JA, Arenas M, Ansari A, Sumi S, Lewis CM, et al. (October 2004). "Mutation in the ITPA gene predicts intolerance to azathioprine". Nucleosides, Nucleotides & Nucleic Acids. 23 (8–9): 1393–1397. doi:10.1081/NCN-200027639. PMID 15571265. S2CID 86308163.
  • Marinaki AM, Sumi S, Arenas M, Fairbanks L, Harihara S, Shimizu K, et al. (October 2004). "Allele frequency of inosine triphosphate pyrophosphatase gene polymorphisms in a Japanese population". Nucleosides, Nucleotides & Nucleic Acids. 23 (8–9): 1399–1401. doi:10.1081/NCN-200027641. PMID 15571266. S2CID 36126159.
  • Maeda T, Sumi S, Ueta A, Ohkubo Y, Ito T, Marinaki AM, et al. (August 2005). "Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency in the Japanese population". Molecular Genetics and Metabolism. 85 (4): 271–279. doi:10.1016/j.ymgme.2005.03.011. PMID 15946879.
  • Breen DP, Marinaki AM, Arenas M, Hayes PC (2005). "Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation". Liver Transplantation. 11 (7): 826–833. doi:10.1002/lt.20377. PMID 15973722. S2CID 9301778.
  • Porta J, Kolar C, Kozmin SG, Pavlov YI, Borgstahl GE (November 2006). "Structure of the orthorhombic form of human inosine triphosphate pyrophosphatase". Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 62 (Pt 11): 1076–1081. doi:10.1107/S1744309106041790. PMC 2225220. PMID 17077483.
  • Arenas M, Duley J, Sumi S, Sanderson J, Marinaki A (January 2007). "The ITPA c.94C>A and g.IVS2+21A>C sequence variants contribute to missplicing of the ITPA gene". Biochimica et Biophysica Acta. 1772 (1): 96–102. doi:10.1016/j.bbadis.2006.10.006. PMID 17113761.
  • Stenmark P, Kursula P, Flodin S, Gräslund S, Landry R, Nordlund P, et al. (February 2007). "Crystal structure of human inosine triphosphatase. Substrate binding and implication of the inosine triphosphatase deficiency mutation P32T". The Journal of Biological Chemistry. 282 (5): 3182–3187. doi:10.1074/jbc.M609838200. PMID 17138556.
  • Atanasova S, Shipkova M, Svinarov D, Mladenova A, Genova M, Wieland E, et al. (February 2007). "Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in exon 6". Therapeutic Drug Monitoring. 29 (1): 6–10. doi:10.1097/FTD.0b013e3180308554. PMID 17304144. S2CID 7286658.

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000125877Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000074797Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Lin S, McLennan AG, Ying K, Wang Z, Gu S, Jin H, et al. (May 2001). "Cloning, expression, and characterization of a human inosine triphosphate pyrophosphatase encoded by the itpa gene". The Journal of Biological Chemistry. 276 (22): 18695–18701. doi:10.1074/jbc.M011084200. PMID 11278832.
  6. ^ a b c "Entrez Gene: ITPA inosine triphosphatase (nucleoside triphosphate pyrophosphatase)".
  7. ^ Burgis NE, Cunningham RP (2007). "Substrate specificity of RdgB protein, a deoxyribonucleoside triphosphate pyrophosphohydrolase". The Journal of Biological Chemistry. 282 (8): 3531–3538. doi:10.1074/jbc.M608708200. PMID 17090528.
  8. ^ a b Davies O, Mendes P, Smallbone K, Malys N (2012). "Characterisation of multiple substrate-specific (d)ITP/(d)XTPase and modelling of deaminated purine nucleotide metabolism". BMB Reports. 45 (4): 259–264. doi:10.5483/BMBRep.2012.45.4.259. PMID 22531138.
  9. ^ Pasin F, Daròs JA, Tzanetakis IE (July 2022). "Proteome expansion in the Potyviridae evolutionary radiation". FEMS Microbiology Reviews. 46 (4) fuac011. doi:10.1093/femsre/fuac011. PMC 9249622. PMID 35195244.
  10. ^ Nyström K, Wanrooij PH, Waldenström J, Adamek L, Brunet S, Said J, et al. (October 2018). "Inosine Triphosphate Pyrophosphatase Dephosphorylates Ribavirin Triphosphate and Reduced Enzymatic Activity Potentiates Mutagenesis in Hepatitis C Virus". Journal of Virology. 92 (19): 01087–01018. doi:10.1002/hep.27009. PMC 6146798. PMID 30045981.
  11. ^ Rembeck K, Waldenstrom J, Hellstrand K, Nilsson S, Nyström K, Martner A, et al. (June 2014). "Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3". Hepatology. 59 (6). Baltimore, Md.: 2131–2139. doi:10.1002/hep.27009. PMID 24519039.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.